From: Crude incidence in two-phase designs in the presence of competing risks
 | Treatment protocol |  | ||
---|---|---|---|---|
 | Standard | Medium | High |  |
 | n s /N s (%) | Total | ||
No relapse | 54/487 (11.1) | 193/987 (19.6) | 109/219 (49.8) | 356/1693 |
Relapse | 21/28 (75.0) | 147/186 (79.0) | 77/92 (83.7) | 245/306 |
Total | 75/515 | 340/1173 | 186/311 | 601/1999 |